Lombard Medical postpones $60 million IPO

By
A A A

Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, postponed its IPO on Friday, citing poor market conditions. The Oxfordshire, United Kingdom-based company was founded in 2003 and booked $7 million in sales for the 12 months ended 12/31/2013. Lombard Medical initially filed confidentially on 1/22/2014. Jefferies & Co. and Barclays were set to be the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: EVAR

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com